U.S. Physical Therapy (USPH) Projected to Post Earnings on Wednesday

U.S. Physical Therapy (NYSE:USPH) will likely be issuing its Q3 2026 results after the market closes on Wednesday, November 4th. Analysts expect U.S. Physical Therapy to announce earnings of $0.7610 per share and revenue of $214.48 million for the quarter. Parties can find conference call details on the company’s upcoming Q3 2026 earnings report for the latest details on the call scheduled for Thursday, November 5, 2026 at 10:30 AM ET.

U.S. Physical Therapy (NYSE:USPH) last released its quarterly earnings data on Thursday, August 6th. The company reported $0.75 EPS for the quarter, missing the consensus estimate of $0.81 by ($0.06). The company had revenue of $214.06 million for the quarter, compared to the consensus estimate of $211.36 million. During the same period in the previous year, the business posted $0.81 earnings per share. The company’s revenue for the quarter was up 8.5% compared to the same quarter last year. On average, analysts expect U.S. Physical Therapy to post $2.89 EPS for the current fiscal year and $3.42 EPS for the next fiscal year.

U.S. Physical Therapy Trading Down 1.5%

U.S. Physical Therapy stock opened at $87.35 on Wednesday. U.S. Physical Therapy has a 1-year low of $58.19 and a 1-year high of $91.63. The firm has a 50 day simple moving average of $82.44 and a 200 day simple moving average of $76.88.

U.S. Physical Therapy Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, September 11th. Shareholders of record on Friday, August 21st were given a dividend of $0.46 per share. The ex-dividend date was Friday, August 21st. This represents a $1.84 annualized dividend and a dividend yield of 2.1%.

Analysts Set New Price Targets

A number of equities analysts have recently commented on USPH shares. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of U.S. Physical Therapy in a report on Wednesday, August 26th. Barrington Research boosted their price objective on U.S. Physical Therapy from $90.00 to $98.00 and gave the company an “outperform” rating in a research note on Monday, August 10th. JPMorgan Chase & Co. increased their price objective on U.S. Physical Therapy from $90.00 to $95.00 and gave the stock an “overweight” rating in a report on Friday, September 11th. Finally, Citigroup reissued a “market outperform” rating on shares of U.S. Physical Therapy in a report on Wednesday, August 19th. One investment analyst has rated the stock with a Strong Buy rating, four have given a Buy rating and two have assigned a Hold rating to the stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $98.25.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc (NYSE: USPH) operates outpatient physical therapy clinics throughout the United States. The company provides treatment and rehabilitation services for patients recovering from injuries, surgeries, illnesses and other conditions that affect movement, strength and physical function.

In addition to company-operated clinics, U.S. Physical Therapy develops and manages physical therapy practices in partnership with local physical therapists. Its services generally include orthopedic and sports rehabilitation, post-operative therapy, treatment for musculoskeletal conditions and other forms of outpatient rehabilitation.